Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSP 301 (Ryaltris) in Seasonal Allergic Rhinitis
NCT02870205Phase 3Completed
- Sponsor
- Glenmark Specialty
- Start
- Aug 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olopatadine, mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Glenmark Specialty. Started Aug 2016; status: completed.
02
Drugs
olopatadinemometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02870205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02870205.